MiNK Therapeutics (INKT) Misses Q3 EPS by 65c

MiNK Therapeutics (NASDAQ: INKT) reported Q3 EPS of ($0.65).

For earnings history and earnings-related data on MiNK Therapeutics (INKT) click here.

You May Also Be Interested In

• Rex American Resources Corp. (REX) Tops Q2 EPS by 64c
• DDC reports 29% food revenue rise and bitcoin treasury growth
• Deutsche Bank Upgrades Sirius XM Radio (SIRI) to Buy, 'mispriced based on a large disconnect between consensus estimates and what we believe the company can achieve